• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依托度酸纳米混悬剂凝胶剂用于增强经皮给药:制备与评价。

Etodolac nanosuspension based gel for enhanced dermal delivery: and evaluation.

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Ankara, Turkey.

Department of Pharmacology, Faculty of Pharmacy, Gazi University, Ankara, Turkey.

出版信息

J Microencapsul. 2021 Jun;38(4):218-232. doi: 10.1080/02652048.2021.1895344. Epub 2021 Mar 23.

DOI:10.1080/02652048.2021.1895344
PMID:33752553
Abstract

AIM

The objective of this study was to develop dermal nanosuspension (NS) based gel formulation of etodolac (ETD).

METHODS

Etodolac nanosuspension (ETD-NS) was prepared by wet milling method and dispersed in hydroxypropyl methylcellulose (NS-HPMC) or hydroxyethyl cellulose (NS-HEC) gels. Rheologic and mechanical properties were investigated. and permeability studies were performed. Topical anti-inflammatory and analgesic activity were evaluated in regard to carrageenan-induced inflammatory paw oedema and radiant heat tail-flick method, respectively.

RESULTS

The ETD-NS with approximately 190 nm particle size (PS), 0.16 polydispersity index (PDI), and -15 mV zeta potential (ZP) values were obtained. The work of bioadhesion values of NS-HEC and NS-HPMC gels were 0.229 mJ/cm for both gels. Dermal permeation of ETD from NS-HEC gel (7.18%) was found significantly higher than the NS-HPMC gel (4.56%). Enhanced anti-inflammatory and analgesic activity of NS-HEC gels were observed in comparison with micronised ETD.

CONCLUSIONS

ETD-NS based gel formulation is promising for topical delivery of ETD.

摘要

目的

本研究旨在开发依托考昔(ETD)的透皮纳米混悬剂(NS)凝胶制剂。

方法

采用湿磨法制备依托考昔纳米混悬剂(ETD-NS),并将其分散在羟丙甲纤维素(NS-HPMC)或羟乙基纤维素(NS-HEC)凝胶中。考察了流变学和力学性能,并进行了渗透性研究。通过角叉菜胶诱导的炎性足肿胀和辐射热尾 flick 法分别评价了局部抗炎和镇痛活性。

结果

得到了粒径约为 190nm(PS)、0.16 多分散指数(PDI)和-15mV 动电电势(ZP)的 ETD-NS。NS-HEC 和 NS-HPMC 凝胶的生物粘附功值均为 0.229mJ/cm。从 NS-HEC 凝胶中渗透的 ETD(7.18%)明显高于 NS-HPMC 凝胶(4.56%)。与微米化 ETD 相比,NS-HEC 凝胶表现出增强的抗炎和镇痛活性。

结论

依托考昔 NS 凝胶制剂有望成为依托考昔的局部递药系统。

相似文献

1
Etodolac nanosuspension based gel for enhanced dermal delivery: and evaluation.依托度酸纳米混悬剂凝胶剂用于增强经皮给药:制备与评价。
J Microencapsul. 2021 Jun;38(4):218-232. doi: 10.1080/02652048.2021.1895344. Epub 2021 Mar 23.
2
Preparation and in vitro / in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application.用于皮肤给药的氟比洛芬纳米混悬液凝胶的制备及体外/体内评价
Eur J Pharm Sci. 2020 Dec 1;155:105548. doi: 10.1016/j.ejps.2020.105548. Epub 2020 Sep 13.
3
Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.基于纳米混悬剂的氟比洛芬凝胶的经皮传递增强:开发及体外渗透、药代动力学评价。
Pharm Res. 2021 Jun;38(6):991-1009. doi: 10.1007/s11095-021-03060-6. Epub 2021 Jun 4.
4
Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.湿磨法制备依托度酸纳米混悬剂的处方和工艺参数研究。
Pharm Res. 2020 May 31;37(6):111. doi: 10.1007/s11095-020-02815-x.
5
In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.依托度酸在亲水性凝胶中的体外和离体渗透研究以及萜类化合物作为渗透促进剂的作用
Drug Deliv. 2007 Oct;14(7):453-9. doi: 10.1080/10717540701603746.
6
Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery.通过优化和比较评价依托度酸囊泡凝胶的经皮给药设计。
Drug Dev Ind Pharm. 2019 Apr;45(4):611-628. doi: 10.1080/03639045.2019.1569030. Epub 2019 Feb 4.
7
Nanostructured Etodolac Carriers in Transdermal Gel: Optimization and Characterization.载有埃托啡洛的纳米结构载体经皮凝胶:优化与特性研究。
Pharm Nanotechnol. 2023 Jun 6;11(3):276-293. doi: 10.2174/2211738511666230111110340.
8
Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study.基于纳米结构脂质载体(NLC)的凝胶制剂作为依托度酸的递药系统:从凝胶制备到渗透研究。
Molecules. 2022 Dec 28;28(1):235. doi: 10.3390/molecules28010235.
9
Propellant Free Pressurized Spray System of Etodolac to Manage Acute Pain Conditions: In Vitro and In Vivo Evaluation.依托度酸无推进剂压力喷雾系统治疗急性疼痛:体外与体内评估。
AAPS PharmSciTech. 2024 May 14;25(5):112. doi: 10.1208/s12249-024-02807-9.
10
Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.基于普朗尼克和卵磷脂的自组装器官凝胶用于依托度酸的持续释放:体外和体内相关性。
Curr Drug Deliv. 2017;14(7):926-934. doi: 10.2174/1567201813666160902151514.

引用本文的文献

1
A QbD-Navigated Approach to the Development and Evaluation of Etodolac-Phospholipid Complex Containing Polymeric Films for Improved Anti-Inflammatory Effect.一种基于质量源于设计的方法用于开发和评估含聚合物膜的依托度酸-磷脂复合物以提高抗炎效果
Polymers (Basel). 2024 Sep 4;16(17):2517. doi: 10.3390/polym16172517.
2
Role of Phytoactive-based Nanoformulation for the Treatment of Arthritis.基于植物活性成分的纳米制剂在关节炎治疗中的作用。
Curr Pharm Biotechnol. 2024 Mar 14. doi: 10.2174/0113892010276916240308082328.
3
Nanosuspension-Based Drug Delivery Systems for Topical Applications.
基于纳米混悬剂的经皮给药系统。
Int J Nanomedicine. 2024 Jan 25;19:825-844. doi: 10.2147/IJN.S447429. eCollection 2024.
4
Exploring the therapeutic potential of sodium deoxycholate tailored deformable-emulsomes of etodolac for effective management of arthritis.探讨脱氧胆酸钠定制的依托度酸变形乳液在关节炎有效治疗中的治疗潜力。
Sci Rep. 2023 Dec 7;13(1):21681. doi: 10.1038/s41598-023-46119-7.
5
Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization.纳米乳剂作为依托度酸局部给药的有前景载体:制剂开发与表征
Pharmaceutics. 2023 Oct 23;15(10):2510. doi: 10.3390/pharmaceutics15102510.
6
Investigation of boron nanosized particles prepared with various surfactants and chitosan in terms of physical stability and cell viability.研究用各种表面活性剂和壳聚糖制备的硼纳米颗粒的物理稳定性和细胞活力。
Turk J Chem. 2022 Jul 3;46(5):1429-1449. doi: 10.55730/1300-0527.3449. eCollection 2022.
7
Formulation Strategies of Nanosuspensions for Various Administration Routes.用于不同给药途径的纳米混悬液的制剂策略
Pharmaceutics. 2023 May 17;15(5):1520. doi: 10.3390/pharmaceutics15051520.
8
Development of a Standardized Method for Measuring Bioadhesion and Mucoadhesion That Is Applicable to Various Pharmaceutical Dosage Forms.适用于各种药物剂型的生物黏附与黏膜黏附测量标准化方法的开发。
Pharmaceutics. 2022 Sep 21;14(10):1995. doi: 10.3390/pharmaceutics14101995.